Skip to main content
    H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $461.15
    +11.15 (+2.48%)

    Market Cap: $54.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Humana Inc (HUM) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Humana (HUM) to earn $9.52 per share in the fiscal year ending Dec 31, 2026, on revenue of $162.91B. Of 26 analysts, 16 rate the stock Buy or Strong Buy, 9 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 26 ratings average 2.31, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 62% of the ratings.

    RatingAnalystsShare
    Strong Buy311.5%
    Buy1350.0%
    Hold934.6%
    Sell13.8%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    26

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 89.9% and revenue estimates rise 6.5%.

    Fiscal year ending Dec 31, 2026
    $9.52
    EPS consensus, revenue $162.91B
    Fiscal year ending Dec 31, 2027
    $18.08
    EPS consensus, revenue $173.57B
    Next report
    Feb 9, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$9.52$9.05 to $10.4323$162.91B$162.00B to $164.24B17
    Dec 31, 2027$18.08$13.34 to $23.4025$173.57B$162.56B to $183.10B21

    Quarterly Estimates

    The EPS consensus rises from -$7.60 for the quarter ending Dec 31, 2026 to $13.15 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$7.60-$7.68 to -$6.9427$41.98B$40.05B to $46.75B21
    Mar 31, 2027$13.15$11.21 to $15.6015$42.99B$41.13B to $44.94B10

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 17 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202661
    Fiscal year ending Dec 31, 202770
    Quarter ending Mar 31, 202740

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.0% from $9.15.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$9.52$9.16$9.16$9.15$9.15+4.0%
    Fiscal year ending Dec 31, 2027$18.08$17.09$17.09$16.57$16.57+9.1%
    Quarter ending Mar 31, 2027$13.15$12.33$12.33$12.21$12.24+7.5%

    Frequently Asked Questions About HUM

    What is the HUM stock forecast?

    Consensus analyst estimates put Humana's EPS at $9.52 for the fiscal year ending Dec 31, 2026, on revenue of $162.91B. The consensus rating from 26 analysts is Buy.

    How do analysts rate HUM stock?

    Of 26 analysts covering Humana, 3 rate it Strong Buy, 13 Buy, 9 Hold, 1 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from HUM next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $9.52, with estimates from $9.05 to $10.43 from 23 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $18.08, with estimates from $13.34 to $23.40 from 25 analysts.

    What revenue do analysts expect from Humana next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $162.91B, with estimates from $162.00B to $164.24B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $173.57B, with estimates from $162.56B to $183.10B.

    How many analysts cover HUM?

    26 analysts rate Humana stock, and 23 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.